A trial looking at a way to help people with advanced cancer plan their care (ACTION)
This trial looked at a way to help people plan their care and at whether this improves quality of life.
Cancer of the large bowel. Waste left from digested food passes from the small bowel to the colon, where fluid and foods are absorbed. The waste then goes through to the rectum (back passage) and then through the anus to be passed out of the body. Also called the large intestine or the bowel.
This trial looked at a way to help people plan their care and at whether this improves quality of life.
This trial is looking at veliparib alongside chemotherapy for bowel cancer that has spread to another part of the body (advanced bowel cancer).
This study was done to find the best way of giving information about healthy eating and activity to people who have had treatment for bowel cancer.
This trial is looking at promoting a healthy lifestyle for people who have had treatment for one of the following types of cancer.
This trial looked at Xilonix for bowel cancer that had grown despite having standard treatment.
This study is looking at peoples’ experiences of symptoms, and how symptoms have affected them.
Five-year relative survival for colon cancer in men is below the European average in England, Wales and Scotland but similar to the European average in Northern Ireland.
Five-year relative survival for colon cancer in women is below the European average in England, Wales and Scotland but similar to the European average in Northern Ireland.
Five-year relative survival for rectal cancer in men is below the European average in England and Wales but similar to the European average in Scotland and Northern Ireland.
Five-year relative survival for rectal cancer in women is below the European average in England but similar to the European average in Wales, Scotland and Northern Ireland.
This study is to see if a scan called a diffusion weighted MRI may help to show up areas of cancer spread more clearly than a CT scan.
This trial looked at a way of doing a colonoscopy that involves spraying a blue dye throughout the large bowel. This is called contrast enhanced colonoscopy.
This trial is looking at axitinib to treat bowel cancer that has spread to another part of the body (advanced bowel cancer).